Showing posts with label Eli Lilly. Show all posts
Showing posts with label Eli Lilly. Show all posts
Friday, June 27, 2025

We added to our position in Viking Therapeutics last week as the summer of Bio Tech M&A moves forward!

›
  Lipid and metabolic disorders are a broad group of conditions that affect how the body processes fats (lipids) and energy.  Here's a ...
Tuesday, February 18, 2025

Will 2025 bring a buyout offer for Viking Therapeutics and their cutting edge drug pipeline? Stay tuned!

›
  Viking Therapeutics (VKTX) – Investment & Business Report (February 2025) Company Overview Viking Therapeutics, Inc. (NASDAQ: VKTX) is...
Friday, January 17, 2025

"NASH" is a serious healthcare problem and it is one important reason why Viking Therapeutics might become a takeover target!

›
  Viking Therapeutics (NASDAQ: VKTX) Viking Therapeutics is a clinical-stage biopharmaceutical company focused primarily on the development ...
Friday, August 2, 2024

As the Quantum age takes shape, the emergence of quantum computing and its capabilities may disrupt various industries. Avoiding these could save an investor a lot of money!

›
   Here are ten types of stocks or specific companies you might want to be cautious about as quantum technology progresses: Cybersecurity Fi...
Wednesday, July 17, 2024

Artificial intelligence like Open Ai and others, are helping healthcare and biotech companies advance medicine! Where might we invest?

›
  Healthcare and biotech companies are partnering with OpenAI to advance their medical technology, including Moderna, Sanofi, Eli Lilly, and...